About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
COPD: Journal of Chronic Obstructive Pulmonary Disease
›
Top Articles
COPD: Journal of Chronic Obstructive Pulmonary Disease
Pulmonology
2
(top 9%)
Impact Factor
2.2
(top 9%)
extended IF
66
(top 6%)
H-Index
1.2K
authors
1.3K
papers
25.8K
citations
2.8K
citing journals
14.2K
citing authors
Most Cited Articles of COPD: Journal of Chronic Obstructive Pulmonary Disease
Title
Year
Citations
Genetic epidemiology of COPD (COPDGene) study design
2010
749
St. George's Respiratory Questionnaire: MCID
2005
586
Identifying individuals with physcian diagnosed COPD in health administrative databases
2009
397
Minimal clinically important differences in COPD lung function
2005
332
Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale
2005
237
Alveolar macrophages as orchestrators of COPD
2004
235
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003
2004
213
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention
2008
203
Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ)
2005
200
The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and Design
2005
191
Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test
2005
190
COPD as a systemic disease
2008
171
The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review
2010
169
Approaches and recommendations for estimating minimally important differences for health-related quality of life measures
2005
158
Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS)
2008
157
The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. 1963
2013
156
Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality
2012
144
The MCID of the transition dyspnea index is a total score of one unit
2005
144
Dyspnea and activity limitation in COPD: mechanical factors
2007
140
Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis
2009
137
Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes
2009
136
Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial
2004
133
Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature
2006
130
Chronic obstructive pulmonary disease and socioeconomic status: a systematic review
2012
124
The clinical importance of dynamic lung hyperinflation in COPD
2006
120
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.